Investigating Emotional Reactivity in Experienced Users of Psychedelics: A Cross‐Sectional fMRI Study
Paweł Orłowski, Aleksandra Domagalik, Michał Bola
Human Brain Mapping April 1, 2026 DOI: 10.1002/hbm.70522 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional fMRI study Preregistered Peer reviewed |
|---|---|
| Sample size | 67 |
| Population | Experienced psychedelic users (≥ 10 lifetime uses) and matched nonusers |
| Topics | Default mode network |
| Keywords | Precuneus Facial expression Anger Reactivity psychology Emotional expression Salience neuroscience Emotion perception Feeling Cognitive psychology Neuroimaging Emotional valence Dissociation chemistry Developmental psychology Subliminal stimuli Emotional behavior Emotional regulation |
| Key findings | Experienced psychedelic users showed enhanced behavioral recognition of angry expressions and altered neural responses to emotional faces, including reduced limbic and salience network activation to anger and increased sensorimotor responses to happiness. |
Abstract
Classic psychedelics profoundly alter emotional states, inducing intense acute experiences lasting hours, followed by subtler, longer-lasting changes in emotional reactivity that can persist for weeks. While experimental and clinical studies document these prolonged effects, the highly context-dependent nature of psychedelic experiences leaves open the question of whether naturalistic, nonclinical use similarly modulates emotional processing. To investigate this, we conducted a preregistered, cross-sectional fMRI study comparing experienced psychedelic users (≥ 10 lifetime uses; N = 33) with closely matched nonusers (N = 34). Participants performed an emotional face recognition task, and we examined behavioral performance and neural responses to angry, happy, and fearful facial expressions. Behavioral results revealed that psychedelic users recognized angry expressions more quickly and accurately, indicating enhanced processing efficiency for threat-related stimuli. Consistent with this, whole-brain fMRI analyses showed reduced activation to anger in key limbic and salience network regions. Psychedelic users also exhibited heightened responses to happy expressions in parietal and sensorimotor cortices-aligning with prior clinical observations-as well as increased precuneus activation to fearful expressions. Region-of-interest analyses further demonstrated reduced differentiation between emotional categories in two default mode network nodes: the frontal medial cortex and parahippocampal gyrus. These findings provide a nuanced characterization of neurofunctional changes in emotional processing linked to repeated naturalistic psychedelic use. By bridging clinical and real-world contexts, this work deepens our understanding of the potential long-term consequences of psychedelics and complements existing evidence from controlled therapeutic settings.
Comparable studies
Other experimental studies on default mode network, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Functional connectivity of default mode network components: Correlation, anticorrelation, and causality Healthy subjects | 2008 | Observational study using resting-state fMRI and seed correlation analysis | |
| Patterns of Brain Activity Supporting Autobiographical Memory, Prospection, and Theory of Mind, and Their Relationship to the Default Mode Network Healthy subjects | 2009 | Experimental study using fMRI | |
| Dynamic reconfiguration of the default mode network during narrative comprehension Human subjects | 2016 | Experimental study | |
| Broadband Cortical Desynchronization Underlies the Human Psychedelic State Healthy human participants | 2013 | Experimental study | |
| The brain on art: intense aesthetic experience activates the default mode network Human observers | 2012 | Observational study with fMRI and behavioral analysis |
Citations in the library
Cites 26
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
and 21 more in the library